Literature DB >> 26239723

Two novel compound heterozygous mutations in the BCKDHB gene that cause the intermittent form of maple syrup urine disease.

Yi Guo1, Liu Liming2, Li Jiang3,4.   

Abstract

Intermittent maple syrup urine disease (MSUD) is a potentially life-threatening metabolic disorder caused by a deficiency of branched chain α-ketoacid dehydrogenase (BCKD) complex. In contrast to classic MSUD, children with the intermittent form usually have an atypical clinical manifestation. Here, we describe the presenting symptoms and clinical course of a Chinese boy with intermittent MSUD. Mutation analysis identified two previously unreported mutations in exon 7 of the BCKDHB gene: c.767A > G (p.Y256C) and c.768C > G (p.Y256X); the parents were each heterozygous for one of these mutations. In silico analysis predicted Y256C probably affects protein structure; Y256X leads to a premature stop codon. This case demonstrates intermittent MSUD should be suspected in cases with symptoms of recurrent encephalopathy, especially ataxia or marked drowsiness, which usually present after the neonatal period and in conjunction with infection. symmetrical basal ganglia damage but normal myelination in the posterior limb will assist differential diagnosis; alloisoleucine is a useful diagnostic marker and mutation analysis may be of prognostic value. These novel mutations Y256C and Y256X result in the clinical manifestation of a variant form of MSUD, expanding the mutation spectrum of this disease.

Entities:  

Keywords:  BCKDHB gene; Maple syrup urine disease; Mutation; Variant form

Mesh:

Substances:

Year:  2015        PMID: 26239723     DOI: 10.1007/s11011-015-9711-z

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  13 in total

1.  Analysis of gene mutations in Chinese patients with maple syrup urine disease.

Authors:  Nan Yang; Lianshu Han; Xuefan Gu; Jun Ye; Wenjuan Qiu; Huiwen Zhang; Zhuwen Gong; Yafen Zhang
Journal:  Mol Genet Metab       Date:  2012-06-06       Impact factor: 4.797

2.  Teaching NeuroImages: MRI in maple syrup urine disease.

Authors:  Parayil Sankaran Bindu; Jerry M E Kovoor; Rita Christopher
Journal:  Neurology       Date:  2010-01-19       Impact factor: 9.910

3.  Maple syrup urine disease: diffusion-weighted MRI findings during acute metabolic encephalopathic crisis.

Authors:  Rukiye Kilicarslan; Alpay Alkan; Demet Demirkol; Huseyin Toprak; Rasul Sharifov
Journal:  Jpn J Radiol       Date:  2012-04-03       Impact factor: 2.374

4.  Significance of L-alloisoleucine in plasma for diagnosis of maple syrup urine disease.

Authors:  P Schadewaldt; A Bodner-Leidecker; H W Hammen; U Wendel
Journal:  Clin Chem       Date:  1999-10       Impact factor: 8.327

5.  Two novel mutations in the BCKDHB gene (R170H, Q346R) cause the classic form of maple syrup urine disease (MSUD).

Authors:  Yue-Ping Wang; Man-Long Qi; Ting-Ting Li; Yun-Jing Zhao
Journal:  Gene       Date:  2012-02-03       Impact factor: 3.688

6.  Intermediate maple syrup urine disease: neuroimaging observations in 3 patients from South India.

Authors:  P S Bindu; K E Shehanaz; Rita Christopher; Pramod K Pal; S Ravishankar
Journal:  J Child Neurol       Date:  2007-07       Impact factor: 1.987

7.  Molecular characterization of maple syrup urine disease patients from Tunisia.

Authors:  N Jaafar; A Moleirinho; E Kerkeni; K Monastiri; H Seboui; A Amorim; M J Prata; S Quental
Journal:  Gene       Date:  2013-01-09       Impact factor: 3.688

8.  Roles of His291-alpha and His146-beta' in the reductive acylation reaction catalyzed by human branched-chain alpha-ketoacid dehydrogenase: refined phosphorylation loop structure in the active site.

Authors:  R Max Wynn; Mischa Machius; Jacinta L Chuang; Jun Li; Diana R Tomchick; David T Chuang
Journal:  J Biol Chem       Date:  2003-08-05       Impact factor: 5.157

9.  Branched-chain Ketoacyl Dehydrogenase Deficiency: Maple Syrup Disease.

Authors:  Kevin A. Strauss; D. Holmes Morton
Journal:  Curr Treat Options Neurol       Date:  2003-07       Impact factor: 3.972

10.  Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease.

Authors:  William J Zinnanti; Jelena Lazovic; Kathleen Griffin; Kristen J Skvorak; Harbhajan S Paul; Gregg E Homanics; Maria C Bewley; Keith C Cheng; Kathryn F Lanoue; John M Flanagan
Journal:  Brain       Date:  2009-03-17       Impact factor: 13.501

View more
  3 in total

1.  Two homozygous mutations in the exon 5 of BCKDHB gene that may cause the classic form of maple syrup urine disease.

Authors:  Ling Su; Zhikun Lu; Fatao Li; Yongxian Shao; Huiying Sheng; Yanna Cai; Li Liu
Journal:  Metab Brain Dis       Date:  2017-02-15       Impact factor: 3.584

2.  Clinical characteristics and mutation analysis of five Chinese patients with maple syrup urine disease.

Authors:  Xiaomei Li; Yali Yang; Qing Gao; Min Gao; Yvqiang Lv; Rui Dong; Yi Liu; Kaihui Zhang; Zhongtao Gai
Journal:  Metab Brain Dis       Date:  2018-01-06       Impact factor: 3.584

3.  Silico analysis of a novel mutation c.550delT in a Chinese patient with maple syrup urine disease.

Authors:  Wenjie Li; Xianze Meng; Weiqing Wang; Jinfeng Lv; Yingmei Sun; Yanan Lv; Caijuan Wang; Hongqin Wang; Mei Wang; Dongpo Song
Journal:  Clin Case Rep       Date:  2018-09-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.